跳至主要内容
临床试验/ACTRN12611000165987
ACTRN12611000165987已完成3 期

The use of microarray analysis to examine the effects of an anti-inflammatory intervention containing statins, lycopene and fish oil in COPD.

Hunter New England Health Service0 个研究点目标入组 13 人开始时间: 2011年2月11日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
35 Years 至 75 Years(—)
性别
All

入选标准

  • Ex-smokers with a smoking history of a least 10 pack years, obstructive airway disease (FEV1/FVC ratio < 2SD below expected value for age, sex and height)

排除标准

  • Currently taking lipid lowering drugs or drugs that interact with statins, Subjects with active liver disease, renal impairment, cardiovascular disease, pregnant or breast feeding, subjects with known allergies or intolerance to statins or one of the dietary supplements

研究者

发起方
Hunter New England Health Service

相似试验